


RadiesseRadiesse Filler Wrinkle improvement and volume restoration Radiesse is a 1. 5mg ml dermal filler made of Calcium Hydroxyapatite without lidocaine. Stimulates the naturally occurring collagen beneath the skin. Global Shipping Support for Fillers and Toxins of South korea Sales RADIESSE and RADIESSE (+) are dermal fillers that are used for smoothing moderate to severe facial wrinkles and folds, such as nasolabial folds Radiesse is an injectable filler
Quick Dispatch:
Your Radiesse orders ship within 1-2 business days.
Delivery Options:
- Standard: 3-7 business days
- Fast: 2-3 business days
- Express: 1-2 business days
Order Tracking:
You'll receive a tracking link by email once your Radiesse ships.
Need Help?
Questions about Radiesse, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Radiesse in your area.
Get Shipping Estimates
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
4.2 ★★★★★
Based on 494 reviews
Sort
Product Reviews
★★★★★ 5
ID
Format: Paperback
Excellent resource.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on August 25, 2025
★★★★★ 5
Good book
Format: Paperback
We updated our references at our pharmacy… this is a good one!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 2, 2024
★★★★★ 5
Good.
Format: Paperback
The book arrived in good conditions.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 5, 2024
★★★★★ 5
Comprehensive book on infectious disease
Format: Paperback
A classic reference
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 31, 2024
★★★★★ 5
Great
Format: Paperback
Very useful
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 5, 2024